Search results for "From ACP Internist Weekly"
Text messages may improve glycemic control in patients with diabetes and coronary disease
Patients in a Chinese study received six automated text messages per week with educational and motivational information on glucose monitoring, blood pressure control, medication adherence, physical activity, and lifestyle.
https://diabetes.acponline.org/archives/2019/09/13/9.htm
13 Sep 2019
SGLT-2 inhibitors not associated with increased risk for severe UTIs
An accompanying editorial said that while the study's finding is reassuring, it should be considered with caution, especially since high-risk patients and those with previous urinary tract infections (UTIs) were excluded.
https://diabetes.acponline.org/archives/2019/08/09/7.htm
9 Aug 2019
Antidepressants associated with decreased mortality rates in patients with diabetes and depression
A retrospective cohort study in Taiwan found that antidepressant use was associated with a significantly reduced risk for death, and after adjustment, total mortality decreased as total cumulative antidepressant dose increased.
https://diabetes.acponline.org/archives/2019/07/12/7.htm
12 Jul 2019
Kidney failure, CV events lower with canagliflozin than placebo, industry study finds
The trial was stopped early after an interim safety analysis found significantly better renal and cardiovascular outcomes among type 2 diabetes patients randomized to canagliflozin than those assigned to placebo.
https://diabetes.acponline.org/archives/2019/05/10/10.htm
10 May 2019
SGLT2 inhibitors associated with rare, life-threatening necrotizing genital infections
In the past six years, nearly three times as many cases of Fournier gangrene were reported in patients taking sodium-glucose cotransporter-2 (SGLT2) inhibitors as in the past 35 years in patients taking other antiglycemic agents.
https://diabetes.acponline.org/archives/2019/05/10/11.htm
10 May 2019
Lower glucose levels before hospital discharge associated with readmission, death in diabetes patients
Even near-normal glucose levels on the last day of hospitalization were associated with increased risk for readmission and postdischarge mortality, and these risks increased as patients' glucose levels decreased.
https://diabetes.acponline.org/archives/2019/05/10/12.htm
10 May 2019
New guideline offers recommendations for older patients with diabetes or prediabetes
The Endocrine Society's new clinical practice guideline recommends lifestyle therapy, then metformin, then second-line drugs (but not sulfonylureas and glinides) or insulin for diabetes patients ages 65 years and older, among other advice.
https://diabetes.acponline.org/archives/2019/04/05/6.htm
5 Apr 2019
Canagliflozin may not increase fracture risk in patients at low risk for fractures
Although canagliflozin has been linked to decreased bone mineral density, patients with type 2 diabetes who initiated the drug had similar risk of a first fracture as those who started a glucagon-like peptide-1 receptor agonist.
https://diabetes.acponline.org/archives/2019/01/11/7.htm
11 Jan 2019
Diabetes outcomes similar when primary care provided by NPs, PAs, or physicians, study finds
More care by nurse practitioners (NPs) and physician assistants (PAs) may be a way to expand primary care access while maintaining quality standards.
https://diabetes.acponline.org/archives/2018/12/14/10.htm
14 Dec 2018
Expert panel recommends SGLT2 inhibitor or GLP-1 receptor agonist for patients with type 2 diabetes and CVD
The American College of Cardiology's new decision pathway also calls for repeated HbA1c screening and detailed clinician-patient risk discussions for patients with cardiovascular disease (CVD) who are diagnosed with type 2 diabetes.
https://diabetes.acponline.org/archives/2018/12/14/9.htm
14 Dec 2018